APLN and type 2 diabetes mellitus: Similar results on pancreatic β-cell mass have been obtained in the HFD-fed STZ-induced experimental type 2 diabetic rats receiving a once-daily intraperitoneal injection of apelin (0.1 μmol/kg) for 10 weeks [184].